These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo. Sheldon RJ; Nunan L; Porreca F J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899 [TBL] [Abstract][Full Text] [Related]
44. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice. Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986 [TBL] [Abstract][Full Text] [Related]
45. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists. Murray CW; Cowan A J Pharmacol Exp Ther; 1991 Apr; 257(1):335-41. PubMed ID: 1850470 [TBL] [Abstract][Full Text] [Related]
46. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation. Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324 [TBL] [Abstract][Full Text] [Related]
47. Kappa, but not mu or delta, opioids attenuate responses to distention of afferent fibers innervating the rat colon. Sengupta JN; Su X; Gebhart GF Gastroenterology; 1996 Oct; 111(4):968-80. PubMed ID: 8831591 [TBL] [Abstract][Full Text] [Related]
48. Disability of development of tolerance to morphine and U-50,488H, a selective kappa-opioid receptor agonist, in neuropathic pain model mice. Sounvoravong S; Takahashi M; Nakashima MN; Nakashima K J Pharmacol Sci; 2004 Mar; 94(3):305-12. PubMed ID: 15037816 [TBL] [Abstract][Full Text] [Related]
49. Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis. Russell JA; Coombes JE; Leng G; Bicknell RJ J Physiol; 1993 Sep; 469():365-86. PubMed ID: 8271202 [TBL] [Abstract][Full Text] [Related]
50. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists. Millan MJ; Morris BJ; Herz A J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827 [TBL] [Abstract][Full Text] [Related]
51. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse. Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676 [TBL] [Abstract][Full Text] [Related]
52. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats. Yamamoto T; Ohno M; Ueki S Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208 [TBL] [Abstract][Full Text] [Related]
53. Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Funada M; Suzuki T; Narita M; Misawa M; Nagase H Neuropharmacology; 1993 Dec; 32(12):1315-23. PubMed ID: 7908722 [TBL] [Abstract][Full Text] [Related]
54. Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig. Culpepper-Morgan JA; Holt PR; LaRoche D; Kreek MJ Life Sci; 1995; 56(14):1187-92. PubMed ID: 7475895 [TBL] [Abstract][Full Text] [Related]
55. Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice. Welch SP J Pharmacol Exp Ther; 1993 May; 265(2):633-40. PubMed ID: 8388455 [TBL] [Abstract][Full Text] [Related]
56. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883 [TBL] [Abstract][Full Text] [Related]
57. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade. Pugsley MK; Penz WP; Walker MJ; Wong TM Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979 [TBL] [Abstract][Full Text] [Related]
58. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Kuzmin AV; Semenova S; Gerrits MA; Zvartau EE; Van Ree JM Eur J Pharmacol; 1997 Mar; 321(3):265-71. PubMed ID: 9085036 [TBL] [Abstract][Full Text] [Related]
59. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice. Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913 [TBL] [Abstract][Full Text] [Related]
60. Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a kappa-opioid receptor agonist in mononeuropathic rats. Catheline G; Guilbaud G; Kayser V Eur J Pharmacol; 1998 Sep; 357(2-3):171-8. PubMed ID: 9797033 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]